Join
Live feed
·
INSIDERFilingvia Quantisnow
Zenas BioPharma Inc. logo

Amendment: Chief Executive Officer Moulder Leon O Jr converted options into 693,175 shares, increasing direct ownership by 3,465% to 161,155 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZBIO· Zenas BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZBIO (Zenas BioPharma Inc.) and more on Quantisnow.